First human test: is this new drug safe?
NCT ID NCT03692949
Summary
This was an early-stage study to check the safety and how the body processes a new drug called LY3451838. It involved 53 healthy volunteers who received the drug either through an IV or an injection under the skin. The main goal was to see what side effects might occur and to measure how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore
Conditions
Explore the condition pages connected to this study.